New research paper: Brain stimulation shows promise as a potential treatment for Alzheimer’s
Posted: 25 September 2023 The Bionics Institute’s Professor Kate Hoy has published a pioneering new research paper showing changes in brain activity and cognitive function in Alzheimer’s disease patients following six weeks of a patterned form of magnetic…
Optiscan Correlates with Histology in Breast Study
Posted: 21 September 2023 Optiscan Imaging Limited (ASX: OIL) is pleased to provide an interim readout on its Breast Cancer Intraoperative Assessment Study. The Study, currently being undertaken at the Royal Melbourne, Frances Perry and Epworth Hospitals, involves…
New Milestone For Moderna Vaccine Facility
Posted: 19 September 2023 Thanks to the Andrews Labor Government, Victorians are one step closer to locally manufactured mRNA vaccines and medicines, with construction of Moderna’s mRNA vaccine manufacturing facility reaching the halfway mark, ahead of schedule. Minister…
New Major Asthma Partnership with US-Based SENTA Partners
Posted: 19 September 2023 Adherium Limited (ASX: ADR), a leading digital health company specialising in remote patient monitoring and data solutions for respiratory patients, confirms a new transformative partnership in which SENTA Partners has agreed on a plan…
New discovery for treatment of primary liver cancer
Posted: 19 September 2023 A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular…
Mobius Medical Expands Global Footprint Into United States
Posted: 19 September 2023 Australian Contract Research Organization (CRO) Mobius Medical Expands Global Footprint, Enters United States Market, with a Strategic Focus on Medical Devices. Minneapolis, September 18, 2023 – In a strategic move to enhance its worldwide…
FDA approval for US$1.9B Australian-developed cancer treatment
Posted: 19 September 2023 A cancer drug developed in Australia has received the green light from the US Food and Drug Administration (FDA) as a bone marrow cancer treatment. Momelotinib was invented at Cytopia (ASX: CYT), an Australian…
Neo-Bionica launches onshore critical medical manufacturing process
Posted: 18 September 2023 Advanced MedTech contract manufacturer Neo-Bionica has revealed the expansion of its manufacturing services with the launch of its new hermitization capability – a first for Australian industry. Hermitization is a critical capability in the…
World-first child health study recruits 100,000 participants
Posted: 18 September 2023 A world-first study tracking the health and wellbeing of Victorians, from birth to old age, has reached a recruitment milestone of over 100,000 participants. Murdoch Children’s Research Institute’s Generation Victoria (GenV), one of the world’s largest-ever birth…
Million-dollar US Department of Defense grant for Peter Mac melanoma research
Posted: 18 September 2023 The United States Department of Defense has called on Peter Mac to help in its fight against melanoma, granting a million dollars to researcher Dr Lorey Smith. Melanoma is of particular interest to the…
World first drug to target previously untreatable life-threatening form of ‘bad cholesterol’
Posted: 28 September 2023 A new drug offers a breakthrough world-first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke. High levels of Lipoprotein(a), known as Lp(a) or spoken…
Phase 3 Common Cold Trial Results
Posted: 14 September 2023 Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) announces that trial statisticians have completed their efficacy analysis of the headline results in the Phase 3 trial of Nasodine® Nasal Spray (“Nasodine”) as a treatment for the…
